...
首页> 外文期刊>Cytotherapy >Umbilical cord blood-derived cells for tissue repair
【24h】

Umbilical cord blood-derived cells for tissue repair

机译:脐血来源的细胞用于组织修复

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hematopoietic tissue-derived cells, including stem cells, have been shown to generate solid organ tissue-specific cells. Besides bone marrow and peripheral blood, umbilical cord blood (UCB) has the advantage of being an easily accessible stem cell source provided as a banked cell product. Using the xenogeneic human into NOD/SCID mouse stem cell transplant model preliminary data suggest UCB-derived tissue-specific cells generated in liver, pancreas, CNS and endothelium. In a clinical sex-mismatched UCB transplant setting Y-positive, UCB-derived gastrointestinal epithelial cells and CNS-specific cells have been identified in female patients. The potential therapeutic use of UCB cells for tissue repair is, however, limited by a low total stem cell number available and by HLA-disparity.
机译:造血组织来源的细胞,包括干细胞,已显示出可产生实体器官组织特异性细胞。除骨髓和外周血外,脐带血(UCB)的优势在于它是一种容易获得的干细胞来源,可作为储库的细胞产品提供。将异种人类应用于NOD / SCID小鼠干细胞移植模型,初步数据表明,在肝脏,胰腺,CNS和内皮细胞中产生了UCB衍生的组织特异性细胞。在临床性别不匹配的UCB移植中,Y呈阳性,已在女性患者中鉴定出UCB衍生的胃肠道上皮细胞和CNS特异性细胞。但是,UCB细胞在组织修复中的潜在治疗用途受到总干细胞数量少和HLA差异的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号